Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture

Transplantation

Volumn 64, Issue 1, 1997, Pages 108-113

  Boeckh, Michael ^a   Gallez Hawkins, Ghislaine M ^b   Myerson, David ^a   Zaia, John A ^b   Bowden, Raleigh A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS DNA;

ACCURACY; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; VIREMIA; VIRUS CULTURE;

ANTIGENS, VIRAL; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GANCICLOVIR; GRAFT REJECTION; HUMANS; LEUKOCYTES, MONONUCLEAR; PHARYNX; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

EID: 0030789609     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707150-00020     Document Type: Article

References (39)

1. Goodrich JM, Mori M, Gleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 325: 1601.
2. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991; 324: 1005.
3. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118: 173.
4. Einsele H, Ehninger G, Hebart H, et al. Polymerase chain reaction monitoring reduces the incidence of CMV disease and the duration and side effects of antiviral therapy after BMT. Blood 1995; 86: 2815.
5. Einsele H, Steidle M, Vallbracht A, Saal JG, Ehninger G, Müller CA. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 1991; 77: 1104.
6. Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyers JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358.
7. Schmidt CA, Oettle H, Wilborn F, et al. Demonstration of cytomegalovirus after marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes. Bone Marrow Transplant 1994; 13: 71.
8. The TH, van der Ploeg M, van der Berg AP, Vlieger Am, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193.
9. Boeckh M, Gooley T, Myerson D, Schoch GH, Cunningham T, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplant: a randomized double-blind study. Blood 1996; 88: 4063.
10. Ishigaki S, Takeda M, Kura T, et al. Cytomegalovirus DNA in the sera of patients with cytomegalovirus pneumonia. Br J Hematol 1991; 79: 198.
11. Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993; 56: 330.
12. Gerna G, Furione M, Baldanti F, Sarasani A. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol 1994; 32: 2709.
13. Freymuth F, Geentay E, Petitjean J, et al. Comparison of nested PCR for detection of DNA in plasma with pp65 leukocyte anti-genemia procedure for the diagnosis of human cytomegalovirus infection. J Clin Microbiol 1994; 32: 1614.
14. Patel R, Smith TF, Espy M, et al. Detection of cytomegalovirus DNA in sera of transplant recipients. J Clin Microbiol 1994; 32: 1431.
15. Brytting M, Xu W, Wahren B, Sundqvist VA. Cytomegalovirus DNA in sera from patients with active cytomegalovirus infection. J Clin Microbiol 1992; 30: 1937.
16. Brytting M, Mousavijazi M, Bostrom L, et al. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Transplantation 1995; 60: 961.
17. Patel R, Smith TF, Espy M, et al. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis 1995; 171: 1010.
18. Nolte FS, Emmens RK, Thurmond C, et al. Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification. J Clin Microbiol 1995; 33: 1263.
19. Yuen KY, Lo SKF, Chiu EKW, et al. Monitoring of leukocyte cytomegalovirus DNA in bone marrow transplant recipients by nested PCR. J Clin Microbiol 1995; 33: 2530.
20. Aspin MM, Gallez-Hawkins GM, Giugni TD, et al. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol 1994; 32: 2266.
21. Spector SA, Merrill R, Wolf D, Dankner WM. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992; 30: 2359.
22. Hebart H, Müller C, Löffler J, Jahn G, Einsele H. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Bone Marrow Transplant 1996; 17: 861.
23. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985; 21: 217.
24. Boeckh M, Gleaves CA, Bindra R, Meyers JD. Comparison of MRC-5 and U-373 MG astrocytoma cells for detection of cytomegalovirus in shell vial centrifugation cultures. Eur J Clin Microbiol Infect Dis 1991; 10: 569.
25. Boeckh M, Woogerd PM, Stevens-Ayers T, Ray CG, Bowden RA. Factors influencing detection of quantitative antigenemia. J Clin Microbiol 1994; 32: 832.
26. Finckh U, Lingenfelter PA, Myerson D. Producing single stranded DNA probes with the Taq DNA polymerase: a high yield protocol. BioTechniques 1991; 10: 35.
27. Myerson D, Lingenfelter PA, Gleaves CA, Meyers JD, Bowden RA. Diagnosis of cytomegalovirus pneumonia by the polymerase chain reaction with archived frozen lung tissue and bronchoalveolar lavage fluid. Am J Clin Pathol 1993; 100: 407.
28. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R. Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol 1993; 83: 602.
29. Schmidt CA, Oettle H, Peng RQ, et al. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplant. Transplantation 1995; 59: 1133.
30. Gerna G, Revello MG, Percivalle E, Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992; 30: 1232.
31. Grundy JE, Ehrnst A, Einsele H, et al. A three-center European quality control study of PCR detection of cytomegalovirus DNA in blood. J Clin Microbiol 1996; 34: 1166.
32. The TH, van den Berg AP, Harmsen MC, van der Bij W, van Son WJ. The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis Suppl 1996; 99: 25.
33. Gerna G, Zipeto D, Percivalle E, et al. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis 1992; 166: 1236.
34. von Lear D, Serr A, Meyer-König U, Kirste G, Hufert FT, Haller O. Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J Infect Dis 1995; 172: 365.
35. Grefte JM, van der Gun, Schmolke BFT, et al. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during active cytomegalovirus infection. J Gen Virol 1992; 73: 2923.
36. Grefte A, Harmsen MC, van der Giessen M, Knollema S, van Son WJ, The TH. Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J Gen Virol 1994; 75: 1989.
37. Grefte A, van der Giessen M, van Son W, The TH. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with active CMV infection. J Infect Dis 1993; 167: 270.
38. Percivalle E, Revello MG, Vago L, Morini F, Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infection with organ involvement. J Clin Invest 1993; 92: 663.
39. Salzberger B, Myerson D, Boeckh M. Circulating CMV-infected endothelial cells in marrow transplant patients with CMV disease and CMV infection. J Infect Dis (in press).